Related Experiment Videos

Isolated mitral valve replacement. With Carpentier-Edwards bioprosthesis :independent risk factors for long-term

H H Kimose1, O Lund, B Ljungström

  • 1Department of Thoracic and Cardiovascular Surgery, Skejby Sygehus, Aarhus University Hospital, Denmark.

Insights

This study identifies key preoperative factors predicting survival and complications after Carpentier-Edwards porcine bioprosthesis mitral valve replacement. A prognostic index was developed to stratify patients into distinct risk groups for better outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Biomaterials Science
  • Clinical Epidemiology

Background:

  • Mitral valve disease necessitates surgical intervention, with bioprosthetic valves offering a common solution.
  • The Carpentier-Edwards porcine bioprosthesis (CEPB) has been utilized for mitral valve replacement, but long-term outcomes require careful prediction.
  • Preoperative patient characteristics significantly influence the success and complication rates of valve replacement surgery.

Purpose of the Study:

  • To identify preoperative predictors of long-term survival following mitral valve replacement with CEPB.
  • To examine the predictability of prosthesis-related complications.
  • To develop a prognostic index for stratifying patient risk.

Main Methods:

  • Retrospective analysis of 188 patients undergoing CEPB for isolated mitral valve disease between 1976 and 1986.
  • Cox regression analysis was employed to determine independent predictors of survival and complications.
  • A prognostic index was calculated based on significant preoperative variables.

Main Results:

  • Five preoperative factors independently predicted long-term survival: myxomatous degeneration, chronic regurgitation, age, NYHA class III-IV, and atrial flutter/fibrillation.
  • A prognostic index stratified patients into six risk groups with significantly different 10-year survival rates (p < 0.0001).
  • Incidence rates for late complications included hemorrhage (1.2%/patient-years), thromboembolism (0.5%/patient-years), endocarditis (1.0%/patient-years), paravalvular leak (0.2%/patient-years), and primary tissue failure (1.5%/patient-years).

Conclusions:

  • Preoperative assessment is crucial for predicting outcomes in patients undergoing CEPB mitral valve replacement.
  • The developed prognostic index effectively categorizes patients into distinct risk strata, aiding in clinical decision-making.
  • Understanding predictors of complications like hemorrhage, endocarditis, and tissue failure can guide preventative strategies.

Related Concept Videos